Rasna Therapeutics (RASP) 10-Q/A 18 Nov 15 2016 Q1 Quarterly report (amended) Financial data

Document and Entity Information

Document and Entity Information - USD ($)	3 Months Ended
	Sep. 30, 2015	Dec. 31, 2014
Document and Entity Information:
Entity Registrant Name	Active With Me Inc.
Document Type	10-Q
Document Period End Date	Sep. 30, 2015
Trading Symbol	awmi
Amendment Flag	true
Amendment Description	1
Entity Central Index Key	1,582,249
Current Fiscal Year End Date	--06-30
Entity Common Stock, Shares Outstanding		3,305,000
Entity Public Float		$ 3,305
Entity Filer Category	Smaller Reporting Company
Entity Current Reporting Status	Yes
Entity Voluntary Filers	No
Entity Well-known Seasoned Issuer	No
Document Fiscal Year Focus	2,016
Document Fiscal Period Focus	Q1

CONDENSED BALANCE SHEETS (UNAUD

CONDENSED BALANCE SHEETS (UNAUDITED) - USD ($)	Sep. 30, 2015	Jun. 30, 2015
Current assets
Cash	$ 1,733	$ 35
Total current assets	1,733	35
Other assets	350	350
Total assets	2,083	385
Current Liabilities
Accounts payable	3,874	4,201
Loan payable to officer and shareholder	10,236	7,236
Current liabilities	14,110	11,437
Total liabilities	14,110	11,437
Stockholders' deficit
Preferred stock	0	0
Common stock	3,305	3,305
Additional paid in capital	47,795	47,795
Accumulated deficit	(63,127)	(62,152)
Stockholders' deficit	(12,027)	(11,052)
Total liabilities and stockholders' deficit	$ 2,083	$ 385

Statement of Financial Position

Statement of Financial Position - Parenthetical - $ / shares	Sep. 30, 2015	Jun. 30, 2014
Statement of Financial Position
Preferred Stock, Par Value	$ 0.001	$ 0.001
Preferred Stock, Shares Authorized	10,000,000	10,000,000
Preferred Stock, Shares Issued	0	0
Preferred Stock, Shares Outstanding	0	0
Common Stock, Par Value	$ 0.001	$ 0.001
Common Stock, Shares Authorized	65,000,000	65,000,000
Common Stock, Shares Issued	3,305,000	3,305,000
Common Stock, Shares Outstanding	3,305,000	3,305,000

CONDENSED STATEMENT OF OPERATIO

CONDENSED STATEMENT OF OPERATIONS (UNAUDITED) - USD ($)	3 Months Ended
	Sep. 30, 2015	Sep. 30, 2014
Operating expenses:
General and administrative	$ 975	$ 3,430
Total operating expenses	975	3,430
Loss from operations	(975)	(3,430)
Net loss	$ (975)	$ (3,430)
Basic and Diluted Loss Per Share	$ 0	$ 0
Weighted average common shares outstanding - basic and diluted	3,305,000	3,305,000

CONDENSED STATEMENT OF CASH FLO

CONDENSED STATEMENT OF CASH FLOWS (UNAUDITED) - USD ($)	3 Months Ended
	Sep. 30, 2015	Sep. 30, 2014
Operating activities:
Net loss	$ (975)	$ (3,430)
Changes in operating assets and liabilities:
Accounts payable (increase/decrease)	(327)	575
Net cash used in operating activities	(1,302)	(2,855)
Financing activities:
Proceeds from loan payable to officer and shareholder (increase/decrease)	3,000	0
Net cash provided by financing activities	3,000	0
Net increase (decrease) in cash	1,698	(2,855)
Cash, beginning of period	35	6,335
Cash, end of period	1,733	3,480
Cash paid for income taxes	0	0
Cash paid for interest	$ 0	$ 0

Note 1 Nature of Business

Note 1 Nature of Business	3 Months Ended
	Sep. 30, 2015
Notes
Note 1 Nature of Business	Note 1 Nature of Business Business Overview Active With Me, Inc., (the “Company”), was incorporated in the State of Nevada on December 6, 2012 to create a web-based service that will offer travelers unique, relevant and user-friendly information on activity-based travel. Listings will be provided for product and service providers of interest to the activity-based traveler. The Company intends to maximize listings on the website, increase the value to the consumer, and provide potential advertisers with an ability to inexpensively feature their services to a very wide and targeted audience.

Note 2 Summary of Significant A

Note 2 Summary of Significant Accounting Policies	3 Months Ended
	Sep. 30, 2015
Notes
Note 2 Summary of Significant Accounting Policies	Note 2 Summary of Significant Accounting Policies Cash Cash equivalents includes highly liquid short-term investments, with original maturities of three months or less. At September 30, 2015, the company had no cash equivalents. Concentration of Risk As of September 30, 2015, the Company maintained its cash account at one commercial bank. The cash balance at September 30, 2015, was within the FDIC coverage of deposits totaling $250,000 per owner. Risks and Uncertainties The Company intends to operate in an industry that is subject to rapid change. The Company’s operations will be subject to significant risk and uncertainties including financial, operational, technological, regulatory, and other risks associated with a development stage company, including the potential risk of business failure. Use of Estimates Our management has made a number of estimates and assumptions relating to the reporting of assets and liabilities and the disclosure of contingent assets and liabilities to prepare these unaudited financial statements in conformity with accounting principles generally accepted in the United States of America. Net Loss per Share Basic loss per share is computed by dividing net loss available to common shareholders by the weighted average number of common shares outstanding during the period. Diluted loss per share includes potentially dilutive securities such as outstanding options and warrants, using various methods such as the treasury stock or modified treasury stock method in the determination of dilutive shares outstanding during each reporting period. As of September 30, 2015, there were no common equivalent shares. Research and Development Costs The Company expenses research and development costs as incurred.

Note 3 Going Concern

Note 3 Going Concern	3 Months Ended
	Sep. 30, 2015
Notes
Note 3 Going Concern	Note 3 Going Concern The accompanying condensed unaudited financial statements have been prepared on a going concern basis, which assumes the Company will realize its assets and discharge its liabilities in the normal course of business. As reflected in the accompanying financial statements, the Company, has a deficit accumulated of $63,127 as of September 30, 2015. The Company’s ability to continue as a going concern is dependent upon its ability to generate future profitable operations and/or to obtain the necessary financing to meet its obligations and repay its liabilities arising from normal business operations when they come due. Management’s plans include obtaining additional funds by equity financing through a reverse merger transaction and/or related party advances; however there is no assurance of additional funding being available. These conditions raise substantial doubt about the Company’s ability to continue as a going concern. The accompanying unaudited condensed financial statements do not include any adjustments that might arise as a result of this uncertainty.

Note 4 Loan Payable To Officer

Note 4 Loan Payable To Officer and Shareholder	3 Months Ended
	Sep. 30, 2015
Notes
Note 4 Loan Payable To Officer and Shareholder	Note 4 Loan Payable to Officer and Shareholder On December 6, 2012, the Company received from its sole Director, President and shareholder, a loan of $605 which such proceeds were utilized to pay for initial organization costs of the Company. During the year ended June 30, 2015, the Company received from its sole Director, President and shareholder an additional loan of $2,631, which such proceeds were utilized to pay for additional operating expenses of the Company. During the year ended June 30, 2015, the Company received from another shareholder, in the aggregate amount of $4,000, which such proceeds were utilized to pay for operational expenses of the Company. During the three months ended September 30, 2015, the Company received from an independent shareholder, in the aggregate amount of $3,000 , which such proceeds were utilized to pay for operational expenses of the Company. The loans are not secured, have no specific maturity dates and the loans are expected to be repaid from future proceeds received by the Company. There are no other terms to the loans. The balance of the loan payable to officer and shareholder in aggregate are $10,236 and $7,236 , as of September 30, 2015 and June 30, 2015, respectively.

Note 5 Stock Holders' Deficit

Note 5 Stock Holders' Deficit	3 Months Ended
	Sep. 30, 2015
Notes
Note 5 Stock Holders' Deficit	Note 5 Stock holders’ Deficit Authorized Shares The Company’s Articles of Incorporation authorize the issuance of up to 10,000,000 shares of $0.001 par value preferred stock. As of September, 2015, there was no preferred stock outstanding. The Company’s Articles of Incorporation authorize the issuance of up to 65,000,000 shares of $0.001 par value common stock. As of September 30, 2015, there were 3,305,000, shares of $0.001 par value common stock issued and outstanding. Issued and Outstanding Shares Since inception, the Company issued 1,500,000 shares of its $.001 par value common stock to its Director, Chief Executive Officer, and President for cash in the amount of $15,000. There were no shares issued during the three months ended September 30, 2015. Since inception, the Company issued 1,805,000 shares of its $.001 par value common stock for cash in the amount of $36,100 to 35 individual accredited investors. There were no shares issued during the three months ended September 30, 2015.

Note 6 Recent Accounting Pronou

Note 6 Recent Accounting Pronouncements	3 Months Ended
	Sep. 30, 2015
Notes
Note 6 Recent Accounting Pronouncements	Note 6 Recent Accounting Pronouncements On June 10, 2014, the FASB issued ASU 2014-10, Development Stage Entities (Topic 915). The amendments in this update remove the definition of a development stage entity from Topic 915, thereby removing the distinction between development stage entities and other reporting entities from U.S. GAAP. In addition, the amendments eliminate the requirements for development stage entities to (1) present inception-to-date information on the statements of income, cash flows, and shareholder’s equity, (2) label the financial statements as those of a development stage entity, (3) disclose a description of the development stage activities in which the entity is engaged, and (4) disclose in the first year in which the entity is no longer a development stage entity that in prior years it had been in the development stage. Early adoption is permitted. The Company adopted ASU 2014-10 since the quarter ended September 30, 2014, thereby no longer presenting or disclosing any information required by Topic 915. In August 2014, the FASB issued ASU No. 2014-15, “Presentation of Financial Statements – Going Concern (Subtopic 205-40): Disclosure of Uncertainties about an Entity’s Ability to Continue as a Going Concern” (“ASU 2014-15”). ASU 2014-15, which is effective for annual reporting periods ending after December 15, 2016, extends the responsibility for performing the going-concern assessment to management and contains guidance on how to perform a going-concern assessment and when going-concern disclosures would be required under U.S. GAAP. The Company elected to adopt ASU 2014-15 effective with this financial statement. Management’s evaluations regarding the events and conditions that raise substantial doubt regarding the Company’s ability to continue as a going concern have been disclosed in this Note 3 – Going Concern.

Note 2 Summary of Significant12

Note 2 Summary of Significant Accounting Policies: Cash (Policies)	3 Months Ended
	Sep. 30, 2015
Policies
Cash	Cash Cash equivalents includes highly liquid short-term investments, with original maturities of three months or less. At September 30, 2015, the company had no cash equivalents.

Note 2 Summary of Significant13

Note 2 Summary of Significant Accounting Policies: Concentration of Risk (Policies)	3 Months Ended
	Sep. 30, 2015
Policies
Concentration of Risk	Concentration of Risk As of September 30, 2015, the Company maintained its cash account at one commercial bank. The cash balance at September 30, 2015, was within the FDIC coverage of deposits totaling $250,000 per owner.

Note 2 Summary of Significant14

Note 2 Summary of Significant Accounting Policies: Risks and Uncertainties (Policies)	3 Months Ended
	Sep. 30, 2015
Policies
Risks and Uncertainties	Risks and Uncertainties The Company intends to operate in an industry that is subject to rapid change. The Company’s operations will be subject to significant risk and uncertainties including financial, operational, technological, regulatory, and other risks associated with a development stage company, including the potential risk of business failure.

Note 2 Summary of Significant15

Note 2 Summary of Significant Accounting Policies: Use of Estimates (Policies)	3 Months Ended
	Sep. 30, 2015
Policies
Use of Estimates	Use of Estimates Our management has made a number of estimates and assumptions relating to the reporting of assets and liabilities and the disclosure of contingent assets and liabilities to prepare these unaudited financial statements in conformity with accounting principles generally accepted in the United States of America.

Note 2 Summary of Significant16

Note 2 Summary of Significant Accounting Policies: Net Loss Per Share (Policies)	3 Months Ended
	Sep. 30, 2015
Policies
Net Loss Per Share	Net Loss per Share Basic loss per share is computed by dividing net loss available to common shareholders by the weighted average number of common shares outstanding during the period. Diluted loss per share includes potentially dilutive securities such as outstanding options and warrants, using various methods such as the treasury stock or modified treasury stock method in the determination of dilutive shares outstanding during each reporting period. As of September 30, 2015, there were no common equivalent shares.

Note 2 Summary of Significant17

Note 2 Summary of Significant Accounting Policies: Research and Development Costs (Policies)	3 Months Ended
	Sep. 30, 2015
Policies
Research and Development Costs	Research and Development Costs The Company expenses research and development costs as incurred.

Note 3 Going Concern (Details)

Note 3 Going Concern (Details) - USD ($)	Sep. 30, 2015	Jun. 30, 2015
Details
Accumulated deficit	$ 63,127	$ 62,152

Note 4 Loan Payable To Office19

Note 4 Loan Payable To Officer and Shareholder (Details) - USD ($)	3 Months Ended
	Sep. 30, 2015	Sep. 30, 2014	Jun. 30, 2015
Details
Proceeds from loan payable to officer and shareholder (increase/decrease)	$ 3,000	$ 0
Loan payable to officer and shareholder	$ 10,236		$ 7,236

Note 5 Stock Holders' Deficit (

Note 5 Stock Holders' Deficit (Details) - $ / shares	Sep. 30, 2015	Jun. 30, 2014
Details
Preferred Stock, Shares Authorized	10,000,000	10,000,000
Preferred Stock, Par Value	$ 0.001	$ 0.001
Common Stock, Shares Authorized	65,000,000	65,000,000
Common Stock, Par Value	$ 0.001	$ 0.001
Common Stock, Shares Issued	3,305,000	3,305,000